CALMARE THERAPEUTICS INCORPORATED

Calmare Therapeutics Incorporated specializes in the development and commercialization of non-pharmacological pain management technologies, leveraging proprietary bioelectronic systems to deliver targeted, non-invasive therapeutic interventions. Their core capabilities center on the design, engineering, and clinical validation of transcutaneous electrical nerve stimulation devices grounded in neuromodulation science, with a focus on chronic pain conditions such as neuropathic pain and complex regional pain syndrome. The company integrates biomedical engineering, clinical neuroscience, and FDA-regulated medical device development processes to deliver Class II devices compliant with 21 CFR Part 820 and ISO 13485 standards. Key differentiators include their patented non-thermal, non-invasive waveform delivery systems and proprietary clinical protocols validated through peer-reviewed studies, positioning them as a niche innovator in alternative pain therapy solutions. Award history is not available to infer specific agency engagements or procurement patterns. Consequently, no definitive agency relationships or federal program alignments can be confirmed based on current data. The primary NAICS code 334510 corresponds to the manufacturing of electromedical and electrotherapeutic apparatus, indicating a focus on the design and production of medical devices for clinical use. The company’s market positioning is within the advanced medical device sector, serving healthcare providers and clinical research institutions through FDA-cleared therapeutic systems rather than traditional government procurement channels. Calmare Therapeutics Incorporated is a small business structured as a limited liability entity headquartered in Shelton, Connecticut. The company holds no active government certifications such as 8(a), HUBZone, or WOSB. Its geographic presence is limited to its operational base, and its government market positioning remains undefined due to lack of publicly available contract performance data.